Skip to main content

Table 4 Summary of selected literature relevant to intermediate energy metabolism in all-cause mortality prediction

From: Systematic review regarding metabolic profiling for improved pathophysiological understanding of disease and outcome prediction in respiratory infections

First author, year, reference

Marker

Study type

Study population

Key findings

Limitations

Ramakrishna et al., 2012, [107]

Lactate

Single-center, observational prospective cohort-study (follow-up until hospital discharge)

233 Malawian children with pneumonia

- The odds ratio for in-hospital mortality (25 deaths) in children with lactate >2 mmol/L was 7.48 (95 % CI 1.72–32.6) compared with children with lactate <2 mmol/L

- Single-center study

- Low statistical power (only 25 deaths)

Chen et al., 2015, [108]

Lactate

Single-center, observational prospective cohort-study (28-day follow-up)

1,641 patients with pneumonia (861 inpatients, 780 outpatients) (Emergency Department of Beijing Chao-Yang Hospital)

- Non-survivors had higher lactate and CURB-65 scores compared with survivors (p < 0.001)

- Single-center study

- No information about microorganisms

- Lactate predicted 28-day mortality better than CURB-65 score (AUC 0.823 vs. 0.692; p < 0.01)

- Combination of lactate and CURB-65 score improved the predictive value of CURB-65 score alone (AUC 0.851)

  1. AUC area under the receiver operating characteristic curve, CI confidence interval, CURB-65 score new-onset confusion, urea >7 mmol/L, respiratory rate ≥30 breaths per minute, systolic or diastolic blood pressure <90 mmHg or ≤60 mmHg, respectively, age ≥65 years (pneumonia/LRTI risk scoring system), p p-value are statistically significant at p < 0.05